LONDON, April 23 (Reuters) - British vaccine maker Acambis Plc has won a long-awaited 10-year contract, worth $425 million, to supply the U.S. government with a smallpox vaccine, the company said on Wednesday.
LONDON, April 23 (Reuters) - British vaccine maker Acambis Plc has won a long-awaited 10-year contract, worth $425 million, to supply the U.S. government with a smallpox vaccine, the company said on Wednesday.
